CN Patent

CN111419817A — 托法替尼口服持续释放剂型

Assigned to Pfizer Inc · Expires 2020-07-17 · 6y expired

What this patent protects

本发明涉及托法替尼口服持续释放剂型。本文所述的制剂具有期望的药代动力学特征。

USPTO Abstract

本发明涉及托法替尼口服持续释放剂型。本文所述的制剂具有期望的药代动力学特征。

Drugs covered by this patent

Patent Metadata

Patent number
CN111419817A
Jurisdiction
CN
Classification
—
Expires
2020-07-17
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.